Tags: ALLTOP | ALLWWCUR | BBCHTO | BBEXCLUDE | BGOVBILLGO | BGOVCODES | BIZNEWS

French Drug Trial Halted After One Patient Becomes Brain Dead

French Drug Trial Halted After One Patient Becomes Brain Dead
(Copyright DPC)

Friday, 15 January 2016 09:08 AM EST

Six people participating in a clinical trial for an experimental drug have been hospitalized after a “serious accident,” France’s Health Ministry said.

One of the people is on life support and is considered brain dead, the ministry said in an e-mailed statement on Friday. The treatment is being developed by a European drugmaker, according to statement, which didn’t name the compound or its developer.

The participants in the early-stage trial were healthy volunteers and the drug was taken orally, the ministry said. The six volunteers were taken to the University Hospital of Rennes, and others who took the treatment are being recalled.

The nation’s drug safety agency ANSM plans to inspect the clinical trial site. Marisol Touraine, the French minister for health, said she will also travel to the hospital and hold a press briefing between 3pm and 4pm Paris time. Her office was informed of the incident on Thursday night.

The drug being tested was a cannabis-based painkiller, according to French daily Le Figaro.

A spokeswoman for the Health Ministry declined to give further details including the laboratory’s name. The Paris prosecutor’s spokeswoman Agnes Thibaut-Lecuivre wasn’t immediately available for comment. Press officers at the ANSM and at the Rennes hospital declined to comment.

--With assistance from Angeline Benoit and Makiko Kitamura.

 

© Copyright 2026 Bloomberg News. All rights reserved.


Health-News
Six people participating in a clinical trial for an experimental drug have been hospitalized after a "serious accident," France's Health Ministry said.One of the people is on life support and is considered brain dead, the ministry said in an e-mailed statement on Friday....
ALLTOP, ALLWWCUR, BBCHTO, BBEXCLUDE, BGOVBILLGO, BGOVCODES, BIZNEWS, BNALL, BNCOPY, BNCOPY2, BNSTAFF, BNTEAMS, BONDWIRES, BUSINESS, CALVPOSS, CLNTRIAL, CLNTRLNON, CMDGLOMAC, CMDKEY, CMDME, COS, CSEUHEADER, DRG, DUPLICATE, EHEALTH, EIND, EMC, EQUITYKEY, EUBNX, EUNRGMKT, EURCURZ5, EUROPE, EUROPEME, EUROSTORY, EURTOP, EURTOPZ5, FINNEWS, FRA, FRCURZ2, FRGOV, FRNEWS, FRTOP, FRTOPZ2, G10MEMB, G7MEMB, GENCURZ2, GENHEA, GENTOP, GENTOPZ2, GOV, GOWEB, HEA, HEACUR, HEACURZ2, HEATOP, HEATOPZ2, HLDUPLICAT, HLNOVEL, HLNOVELTY0, HLNOVELTY8, INDUSTRIES, LST, MAJOR, MEDICAL, METALKEY, MISC, MSCIDVEUR, MSCIWORLD, NOVEL, NOVELTY0, NOVELTY7, NRGKEY, OILKEY, ONWEB, ORIGINAL, POLIRISK, PST, READ, READ100, READ150, READ25, READ250, READ50, REGIONFILT, SPREGIONS, SRCRANK1, STFILT241, STFILT266, TIMECO, TIMENI, TOP, UPDATE, WORLD, WWCUR, WWCURZ6, WWTOP, WWTOPZ6
212
2016-08-15
Friday, 15 January 2016 09:08 AM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
Find Your Condition
Get Newsmax Text Alerts
TOP

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved